U.S. Trade Representative Jamieson Greer said the Trump Administration excluded pharmaceuticals and semiconductors from reciprocal tariffs ...

Stock indexes today are sharply higher, recovering some of the enormous losses over the past three sessions that sent the S&P 500 falling nearly 15% from last Wednesday's close.  Hopes of a tariff ...

CRISTIANO AMON, PRESIDENT AND CEO, QUALCOMM Chip-making giant Qualcomm (NASDAQ:QCOM) derived 46% of its ... RICKS, CEO, ELI LILLY Eli Lilly (NYSE:LLY) secured approvals for weight-loss drug ...

Eli Lilly (LLY) stock gains as Goldman Sachs upgrades it to Buy from Neutral citing the company's leadership position in the ...

The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) had a banner year in 2024. The company's sales surged 32% to over $45 billion on massive growth from its GLP-1 agonist products, Mounjaro for ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...